Understanding the Complexities of Chemotherapy in Pets: A Dialogue with Veterinary Oncologists

Veterinary Vertex

Send us a text

Ever wondered how pet owners and veterinarians perceive chemotherapy in pets differently? Join us as we dissect this emotionally charged topic with veterinary oncologists Abby Leonardi and Michael Childress. We chat about a fascinating study designed to understand these differing perspectives, and the revelations might surprise you. We delve into the heartening finding that pet owners are more prepared than expected to accept higher grade adverse events if it can enhance their pet's quality of life.
At the heart of our conversation is the threefold benefits of chemotherapy for pets: a potential cure for cancer, prolonging life, and improving the quality of life. Abby and Michael also emphasize the significance of pet owners being informed about potential side effects and varying degrees of severity. We navigate this difficult and emotional topic with honesty and heart, reminding us of the resilience and optimism that are cornerstones of their work. So, tune in for an enlightening episode that will leave you with a nuanced understanding of the complex decisions pet owners and veterinarians face when considering chemotherapy for their furry friends.
Full article: https://doi.org/10.2460/javma.23.09.0496

INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ® ?

JAVMA ® : https://avma.org/JAVMAAuthors

AJVR ® : https://avma.org/AJVRAuthors
FOLLOW US:
JAVMA ® :

Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook

Instagram: JAVMA (@avma_javma) • Instagram photos and videos

Twitter: JAVMA (@AVMAJAVMA) / Twitter

AJVR ® :

Facebook: American Journal of Veterinary Research - AJVR | Facebook

Instagram: AJVR (@ajvroa) • Instagram photos and videos

Twitter: AJVR (@AJVROA) / Twitter
JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals

챕터

1. Perceptions of Chemotherapy in Pets (00:00:00)

2. Perceptions of Chemotherapy in Oncology (00:11:29)